XML 71 R94.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation Restricted and Phantom Stock (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Restricted Stock [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense related to award $ 1.5 $ 1.3 $ 1.7    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]          
Beginning balance 760,728 783,289     665,521
Restricted stock awards granted 202,009 149,239 210,536    
Restrictions lapsing 0 0 (15,448)    
Ending balance 556,987 760,728 783,289   665,521
Restricted stock awards outstanding $ 8.51 $ 5.04 $ 6.31 $ 8.02  
Restricted stock awards granted Weighted Average Grate Date Fair Value $ 8.85 $ 10.14 $ 7.00    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) (405,750) (171,800) (77,320)    
Restrictions lapsing Weighted Average Grant Date Fair Value $ 2.17 $ 15.27 $ 22.99    
Director restricted stock [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense related to award 0.3        
Phantom Stock [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense related to award 0.4        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]          
Ending balance 75,816        
Director [Member] | Restricted Stock [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation costs $ 2.0        
Weighted-average period of years costs are expected to be recognied over 1.1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]          
Ending balance 394,358